Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.

PLoS neglected tropical diseases - 1 Jan 2021

Liu Qiao, Yang Dandan, Qiu Beibei, Martinez Leonardo, Ji Ye, Song Huan, Li Zhongqi, Wang Jianming

Abstract excerpt

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) poses a serious challenge to TB control. It is of great value to search for drug resistance mutation sites and explore the roles that they play in the diagnosis and prognosis of MDR-TB. METHODS: We consecutively enrolled MDR-TB patients from five cities in Jiangsu Province, China, between January 2013 and December 2014. Drug susceptibility tests of rifampin,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetyltransferases
Share to Amidohydrolases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Catalase

Share to DNA Gyrase

Share to Isoniazid

Share to Kanamycin

Share to Ofloxacin

Share to Rifampin

Source

Open in PubMed Open full text

Identifiers

PMID: 33471794
DOI: 10.1371/journal.pntd.0009068
PMCID: PMC7850501

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.PMID 33471794Read ↗

pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis.Semantic proximity Read ↗

Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China.Semantic proximity Read ↗

A retrospective cohort study of isoniazid-resistant tuberculosis treatment outcomes and isoniazid resistance-associated mutations in eastern China from 2013 to 2018.Semantic proximity Read ↗

Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.Semantic proximity Read ↗

Detection of genomic mutations in katG and rpoB genes among multidrug-resistant Mycobacterium tuberculosis isolates from Tehran, IranSemantic proximity Read ↗

Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, ChinaSemantic proximity Read ↗

Multidrug-resistant tuberculosis.Semantic proximity Read ↗

Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.Semantic proximity Read ↗

Characteristics and Treatment Outcomes of Isoniazid Mono-Resistant Tuberculosis: A Retrospective Study.Semantic proximity Read ↗

Genetic characterisation of drug-resistant Mycobacterium tuberculosis in rural China: a population-based study.Semantic proximity Read ↗

Drug Susceptibility and Mutation Profiles in Mycobacterium tuberculosis Isolates from a Tertiary Care Hospital in Kerala, India.Semantic proximity Read ↗

Molecular epidemiology and clinical characteristics of drug-resistant Mycobacterium tuberculosis in a tuberculosis referral hospital in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.